Cochrane · systematic review · CD012277

Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life

Gates, NJ, Rutjes, AWS, Di Nisio, M, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

Dementia and Cognitive Improvement2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
15
current version
GRADE rated
10
No studies
5
Included studies
NR
No studies 5 · 33.3%Ungraded 0 · 0%Very low 3 · 20%Low 7 · 46.7%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Comparison

Population: cognitively healthy people in late life
CD012277.PUB3 (current) · 7 questions
OutcomeEffectEvidenceStatus / GRADE
Global cognitive function measured at the end of the intervention period (12 weeks)
no estimate extracted2 studies · 232 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: episodic memory measured at the end of the intervention period (12 to 17 weeks)
no estimate extracted4 studies · 439 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: speed of processing measured at the end of the intervention period (12 to 16 weeks)
no estimate extracted2 studies · 138 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: executive functioning measured at the end of the intervention period (12 to 17 weeks)
no estimate extracted3 studies · 230 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: working memory measured at the end of the intervention period (12 to 16 weeks)
no estimate extracted3 studies · 392 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Quality of life at the end of the intervention period
no estimate extractedNRNo studies
Number of participants experiencing 1 or more serious adverse events at the end of the intervention period
no estimate extractedNRNo studies

Comparison

Population: cognitively healthy people in late life
CD012277.PUB3 (current) · 8 questions
OutcomeEffectEvidenceStatus / GRADE
Global cognitive function measured at the end of the intervention period
no estimate extractedNRNo studies
Cognitive subdomain: episodic memory measured at the end of the intervention period (6 months)
no estimate extracted1 study · 150 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: speed of processing measured at the end of the intervention period (12 to 16 weeks)
no estimate extracted2 studies · 204 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: executive functioning measured at the end of the intervention period (12 weeks to 6 months)
no estimate extracted2 studies · 292 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: working memory measured at the end of the intervention period (16 weeks)
no estimate extracted1 study · 60 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: verbal fluency measured at the end of the intervention period (6 months)
no estimate extracted1 study · 150 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Quality of life at the end of the intervention period
no estimate extractedNRNo studies
Number of participants experiencing 1 or more serious adverse events at the end of the intervention period
no estimate extractedNRNo studies

Comparison

Population: cognitively healthy people in late life
CD012277.PUB2 · 7 questions
OutcomeEffectEvidenceStatus / GRADE
Global cognitive function measured at the end of
no estimate extracted2 studies · 198 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: episodic memory measured at the end of
no estimate extracted4 studies · 439 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: speed of processing measured at the end of
no estimate extracted2 studies · 138 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: executive functioning measured at the end of
no estimate extracted3 studies · 230 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: working memory measured at the end of
no estimate extracted3 studies · 392 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Quality of life
no estimate extractedNRNo studies
Number of participants experiencing 1 or more serious adverse events
no estimate extractedNRNo studies

Comparison

Population: cognitively healthy people in late life
CD012277.PUB2 · 8 questions
OutcomeEffectEvidenceStatus / GRADE
Global cognitive function measured at the end of
no estimate extractedNRNo studies
Cognitive subdomain: episodic memory measured at the end of
no estimate extracted1 study · 150 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: speed of processing measured at the end of
no estimate extracted2 studies · 204 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: executive functioning measured at the end of
no estimate extracted2 studies · 292 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: working memory measured at the end of
no estimate extracted1 study · 60 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Cognitive subdomain: verbal fluency measured at the end of
no estimate extracted1 study · 150 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Quality of life
no estimate extractedNRNo studies
Number of participants experiencing 1 or more serious adverse events
no estimate extractedNRNo studies